Ghent University Academic Bibliography

Journal Article
A1
open access

Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures

Adam Gater, Linda Nelsen, Cheryl D Coon, Sonya Eremenco, Sean O’Quinn, Asif H. Khan (UGent) , Laurent Eckert, Hannah Staunton, Nicola Bonner, Rebecca Hall, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(5). p.1249-1259

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 205(1). p.17-35

Add to list

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) ARCHIVOS DE BRONCONEUMOLOGIA. 58(1). p.35-51

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(1). p.S1-S18

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) RESPIROLOGY. 27(1). p.14-35

Add to list

Journal Article
A1
open access

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Debbie J. Maurer, Chengyao Liu, Paraskevi Xepapadaki, Barbara Stanic, Claus Bachert (UGent) , Susetta Finotto, Ya‐Dong Gao, Anna Graser, Tuomas Jartti, Walter Kistler, et al.

(2022) ALLERGY. 77(4). p.1216-1230

Add to list

Journal Article
A1
open access

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244

Add to list

Journal Article
A1
open access

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, Nobuo Ohta, Mikiya Asako, Claus Bachert (UGent) , Tomoyuki Inoue, Yoshinori Takahashi, Hiroyuki Fujita, Yamo Deniz, et al.

(2022) ALLERGY. 77(1). p.186-196

Add to list

PhD Thesis

MicroRNAs in Asthma and COPD : from biomarkers to regulators of disease pathogenesis

Mirjam Roffel (UGent)

(2022)

Add to list

Journal Article
A1
open access

Unlocking the secrets of long non-coding RNAs in asthma

Fien Gysens (UGent) , Pieter Mestdagh (UGent) , Eric de Bony de Lavergne (UGent) and Tania Maes (UGent)

(2022) THORAX. 77(5). p.514-522

Academic Bibliography

Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

MicroRNAs in Asthma and COPD : from biomarkers to regulators of disease pathogenesis

Unlocking the secrets of long non-coding RNAs in asthma

Contents

Support

Contact